18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
or 16 18 16 18 O
older 19 24 19 24 O

< 0 1 25 26 O
50 2 4 27 29 B-upper_bound
% 4 5 29 30 I-upper_bound
must 6 10 31 35 O
be 11 13 36 38 O
on 14 16 39 41 O
a 17 18 42 43 O
stable 19 25 44 50 O
medical 26 33 51 58 O
regimen 34 41 59 66 O

ANC 0 3 67 70 B-clinical_variable
> 4 5 71 72 O
1500 6 10 73 77 B-lower_bound
cells 11 16 78 83 I-lower_bound
/ 16 17 83 84 I-lower_bound
mm3 17 20 84 87 I-lower_bound

AST 0 3 88 91 B-clinical_variable
and 4 7 92 95 O
ALT 8 11 96 99 B-clinical_variable
< 12 13 100 101 O
2.5 14 17 102 105 B-upper_bound
x 18 19 106 107 I-upper_bound
ULN 20 23 108 111 I-upper_bound

Active 0 6 112 118 B-chronic_disease
tuberculosis 7 19 119 131 I-chronic_disease

Administration 0 14 132 146 O
of 15 17 147 149 O
a 18 19 150 151 O
live 20 24 152 156 B-treatment
, 24 25 156 157 O
attenuated 26 36 158 168 B-treatment
vaccine 37 44 169 176 I-treatment
within 45 51 177 183 O
4 52 53 184 185 B-upper_bound
weeks 54 59 186 191 I-upper_bound
before 60 66 192 198 I-upper_bound
Cycle 67 72 199 204 O
1 73 74 205 206 O
, 74 75 206 207 O
Day 76 79 208 211 O
1 80 81 212 213 O
or 82 84 214 216 O
anticipation 85 97 217 229 O
that 98 102 230 234 O
such 103 107 235 239 O
a 108 109 240 241 O
live 110 114 242 246 O
attenuated 115 125 247 257 O
vaccine 126 133 258 265 O
will 134 138 266 270 O
be 139 141 271 273 O
required 142 150 274 282 O
during 151 157 283 289 O
the 158 161 290 293 O
study 162 167 294 299 O

BCG 0 3 300 303 B-chronic_disease
- 3 4 303 304 I-chronic_disease
refractory 4 14 304 314 I-chronic_disease
disease 15 22 315 322 I-chronic_disease
is 23 25 323 325 O
defined 26 33 326 333 O
as 34 36 334 336 O
the 37 40 337 340 O
absence 41 48 341 348 O
of 49 51 349 351 O
a 52 53 352 353 O
complete 54 62 354 362 O
response 63 71 363 371 O
by 72 74 372 374 O
6 75 76 375 376 B-upper_bound
months 77 83 377 383 I-upper_bound
in 84 86 384 386 O
patients 87 95 387 395 O
who 96 99 396 399 O
have 100 104 400 404 O
received 105 113 405 413 O
induction 114 123 414 423 O

BCG 0 3 424 427 B-chronic_disease
- 3 4 427 428 I-chronic_disease
resistant 4 13 428 437 I-chronic_disease
disease 14 21 438 445 I-chronic_disease
is 22 24 446 448 O
defined 25 32 449 456 O
as 33 35 457 459 O
persistent 36 46 460 470 O
or 47 49 471 473 O
recurrent 50 59 474 483 O
disease 60 67 484 491 O
after 68 73 492 497 O
2 74 75 498 499 O
induction 76 85 500 509 O
courses 86 93 510 517 O
of 94 96 518 520 O
BCG 97 100 521 524 O
within 101 107 525 531 O
1 108 109 532 533 B-upper_bound
year 110 114 534 538 I-upper_bound

CIS 0 3 539 542 B-chronic_disease
, 3 4 542 543 O
high 5 9 544 548 O
- 9 10 548 549 O
grade 10 15 549 554 O
Ta 16 18 555 557 O
, 18 19 557 558 O
any 20 23 559 562 O
grade 24 29 563 568 O
T1 30 32 569 571 O
, 32 33 571 572 O
or 34 36 573 575 O
any 37 40 576 579 O
grade 41 46 580 585 B-lower_bound
cT2 47 50 586 589 I-lower_bound
- 50 51 589 590 O
T4 51 53 590 592 B-upper_bound
, 53 54 592 593 O
considered 55 65 594 604 O
appropriate 66 77 605 616 O
for 78 81 617 620 O
radical 82 89 621 628 B-treatment
cystectomy 90 100 629 639 I-treatment

CTCAE 0 5 640 645 B-clinical_variable
Gr 6 8 646 648 I-clinical_variable
> 9 10 649 650 O
/= 10 12 650 652 O
2 13 14 653 654 B-lower_bound
hearing 15 22 655 662 O
loss 23 27 663 667 O

CTCAE 0 5 668 673 B-clinical_variable
Gr 6 8 674 676 I-clinical_variable
> 9 10 677 678 O
/= 10 12 678 680 O
2 13 14 681 682 B-lower_bound
neuropathy 15 25 683 693 B-chronic_disease

Chronic 0 7 694 701 O
liver 8 13 702 707 B-chronic_disease
disease 14 21 708 715 I-chronic_disease

Clinically 0 10 716 726 O
significant 11 22 727 738 O
active 23 29 739 745 O
infection 30 39 746 755 O
or 40 42 756 758 O
uncontrolled 43 55 759 771 O
medical 56 63 772 779 B-chronic_disease
condition 64 73 780 789 I-chronic_disease

Creatinine 0 10 790 800 B-clinical_variable
clearance 11 20 801 810 I-clinical_variable
less 21 25 811 815 O
than 26 30 816 820 O
60ml 31 35 821 825 B-upper_bound
/ 35 36 825 826 I-upper_bound
min 36 39 826 829 I-upper_bound

ECOG 0 4 830 834 B-clinical_variable
performance 5 16 835 846 I-clinical_variable
status 17 23 847 853 I-clinical_variable
0 24 25 854 855 B-lower_bound
, 25 26 855 856 O
1 27 28 857 858 B-upper_bound

For 0 3 859 862 O
subjects 4 12 863 871 O
with 13 17 872 876 O
NMIBC 18 23 877 882 B-cancer
, 23 24 882 883 O
BCG 25 28 884 887 O
- 28 29 887 888 O
refractory 29 39 888 898 O
or 40 42 899 901 O
BCG 43 46 902 905 O
- 46 47 905 906 O
resistant 47 56 906 915 O
disease 57 64 916 923 O

GFR 0 3 924 927 B-treatment
should 4 10 928 934 O
be 11 13 935 937 O
assessed 14 22 938 946 O
by 23 25 947 949 O
calculation 26 37 950 961 O
from 38 42 962 966 O
serum 43 48 967 972 O
/ 48 49 972 973 O
plasma 49 55 973 979 O
creatinine 56 66 980 990 O
( 67 68 991 992 O
Cockcroft 68 77 992 1001 O
- 77 78 1001 1002 O
Gault 78 83 1002 1007 O
formula 84 91 1008 1015 O
) 91 92 1015 1016 O

HBV 0 3 1017 1020 B-chronic_disease
DNA 4 7 1021 1024 O
must 8 12 1025 1029 O
be 13 15 1030 1032 O
obtained 16 24 1033 1041 O
in 25 27 1042 1044 O
these 28 33 1045 1050 O
patients 34 42 1051 1059 O
prior 43 48 1060 1065 O
to 49 51 1066 1068 O
Cycle 52 57 1069 1074 O
1 58 59 1075 1076 O
, 59 60 1076 1077 O
Day 61 64 1078 1081 O
1 65 66 1082 1083 O
, 66 67 1083 1084 O
but 68 71 1085 1088 O
detection 72 81 1089 1098 O
of 82 84 1099 1101 O
HBV 85 88 1102 1105 O
DNA 89 92 1106 1109 O
in 93 95 1110 1112 O
these 96 101 1113 1118 O
patients 102 110 1119 1127 O
will 111 115 1128 1132 O
not 116 119 1133 1136 O
exclude 120 127 1137 1144 O
study 128 133 1145 1150 O
participation 134 147 1151 1164 O

HIV 0 3 1165 1168 B-chronic_disease
or 4 6 1169 1171 O
active 7 13 1172 1178 O
hepatitis 14 23 1179 1188 B-chronic_disease
B 24 25 1189 1190 I-chronic_disease
virus 26 31 1191 1196 I-chronic_disease
( 32 33 1197 1198 O
HBV 33 36 1198 1201 B-chronic_disease
; 36 37 1201 1202 O
chronic 38 45 1203 1210 O
or 46 48 1211 1213 O
acute 49 54 1214 1219 O
; 54 55 1219 1220 O
defined 56 63 1221 1228 O
as 64 66 1229 1231 O
having 67 73 1232 1238 O
a 74 75 1239 1240 O
positive 76 84 1241 1249 O
hepatitis 85 94 1250 1259 B-clinical_variable
B 95 96 1260 1261 I-clinical_variable
surface 97 104 1262 1269 I-clinical_variable
antigen 105 112 1270 1277 I-clinical_variable
[ 113 114 1278 1279 I-clinical_variable
Bag 114 117 1279 1282 I-clinical_variable
] 117 118 1282 1283 I-clinical_variable
test 119 123 1284 1288 O
at 124 126 1289 1291 O
screening 127 136 1292 1301 O
) 136 137 1301 1302 O
or 138 140 1303 1305 O
active 141 147 1306 1312 O
hepatitis 148 157 1313 1322 B-chronic_disease
C 158 159 1323 1324 I-chronic_disease

Have 0 4 1325 1329 O
available 5 14 1330 1339 O
evaluable 15 24 1340 1349 O
archival 25 33 1350 1358 O
tumor 34 39 1359 1364 B-cancer
tissue 40 46 1365 1371 O
for 47 50 1372 1375 O
PD 51 53 1376 1378 O
- 53 54 1378 1379 O
L1 54 56 1379 1381 O
biomarker 57 66 1382 1391 O
assessment 67 77 1392 1402 O

Hemoglobin 0 10 1403 1413 B-clinical_variable
> 11 12 1414 1415 O
9 13 14 1416 1417 B-lower_bound
g 15 16 1418 1419 I-lower_bound
/ 16 17 1419 1420 I-lower_bound
dL 17 19 1420 1422 I-lower_bound

History 0 7 1423 1430 O
of 8 10 1431 1433 O
autoimmune 11 21 1434 1444 B-chronic_disease
disease 22 29 1445 1452 I-chronic_disease
, 29 30 1452 1453 O
including 31 40 1454 1463 O
but 41 44 1464 1467 O
not 45 48 1468 1471 O
limited 49 56 1472 1479 O
to 57 59 1480 1482 O
myasthenia 60 70 1483 1493 B-chronic_disease
gravis 71 77 1494 1500 I-chronic_disease
, 77 78 1500 1501 O
myositis 79 87 1502 1510 B-chronic_disease
, 87 88 1510 1511 O
autoimmune 89 99 1512 1522 B-chronic_disease
hepatitis 100 109 1523 1532 I-chronic_disease
, 109 110 1532 1533 O
systemic 111 119 1534 1542 B-chronic_disease
lupus 120 125 1543 1548 I-chronic_disease
erythematosus 126 139 1549 1562 I-chronic_disease
, 139 140 1562 1563 O
rheumatoid 141 151 1564 1574 B-chronic_disease
arthritis 152 161 1575 1584 I-chronic_disease
, 161 162 1584 1585 O
inflammatory 163 175 1586 1598 B-chronic_disease
bowel 176 181 1599 1604 I-chronic_disease
disease 182 189 1605 1612 I-chronic_disease
, 189 190 1612 1613 O
vascular 191 199 1614 1622 B-chronic_disease
thrombosis 200 210 1623 1633 I-chronic_disease
associated 211 221 1634 1644 O
with 222 226 1645 1649 O
antiphospholipid 227 243 1650 1666 B-chronic_disease
syndrome 244 252 1667 1675 I-chronic_disease
, 252 253 1675 1676 O
Wegner 254 260 1677 1683 B-chronic_disease
's 260 262 1683 1685 I-chronic_disease
granulomatosis 263 277 1686 1700 I-chronic_disease
, 277 278 1700 1701 O
Sjogren 279 286 1702 1709 B-chronic_disease
's 286 288 1709 1711 I-chronic_disease
syndrome 289 297 1712 1720 I-chronic_disease
, 297 298 1720 1721 O
Guillain 299 307 1722 1730 B-chronic_disease
- 307 308 1730 1731 I-chronic_disease
Barre 308 313 1731 1736 I-chronic_disease
syndrome 314 322 1737 1745 I-chronic_disease
, 322 323 1745 1746 O
multiple 324 332 1747 1755 B-chronic_disease
sclerosis 333 342 1756 1765 I-chronic_disease
, 342 343 1765 1766 O
vacuities 344 353 1767 1776 B-chronic_disease
, 353 354 1776 1777 O
or 355 357 1778 1780 O
glomerulonephritis 358 376 1781 1799 B-chronic_disease

History 0 7 1800 1807 O
of 8 10 1808 1810 O
idiopathic 11 21 1811 1821 B-chronic_disease
pulmonary 22 31 1822 1831 I-chronic_disease
fibrosis 32 40 1832 1840 I-chronic_disease
, 40 41 1840 1841 O
organizing 42 52 1842 1852 B-chronic_disease
pneumonia 53 62 1853 1862 I-chronic_disease
( 63 64 1863 1864 O
e.g. 64 68 1864 1868 O
, 68 69 1868 1869 O
bronchiolitis 70 83 1870 1883 B-chronic_disease
obliterans 84 94 1884 1894 I-chronic_disease
) 94 95 1894 1895 O
, 95 96 1895 1896 O
drug 97 101 1897 1901 O
- 101 102 1901 1902 O
induced 102 109 1902 1909 O
pneumonitis 110 121 1910 1921 B-chronic_disease
, 121 122 1921 1922 O
idiopathic 123 133 1923 1933 B-chronic_disease
pneumonitis 134 145 1934 1945 I-chronic_disease
, 145 146 1945 1946 O
or 147 149 1947 1949 O
evidence 150 158 1950 1958 O
of 159 161 1959 1961 O
active 162 168 1962 1968 O
pneumonitis 169 180 1969 1980 O
on 181 183 1981 1983 O
screening 184 193 1984 1993 O
chest 194 199 1994 1999 B-treatment
CT 200 202 2000 2002 I-treatment
scan 203 207 2003 2007 I-treatment

History 0 7 2008 2015 O
of 8 10 2016 2018 O
radiation 11 20 2019 2028 B-chronic_disease
pneumonitis 21 32 2029 2040 I-chronic_disease
in 33 35 2041 2043 O
the 36 39 2044 2047 O
radiation 40 49 2048 2057 O
field 50 55 2058 2063 O
( 56 57 2064 2065 O
fibrosis 57 65 2065 2073 B-chronic_disease
) 65 66 2073 2074 O
is 67 69 2075 2077 O
permitted 70 79 2078 2087 O

History 0 7 2088 2095 O
of 8 10 2096 2098 O
severe 11 17 2099 2105 O
allergic 18 26 2106 2114 O
, 26 27 2114 2115 O
anaphylactic 28 40 2116 2128 O
, 40 41 2128 2129 O
or 42 44 2130 2132 O
other 45 50 2133 2138 O
hypersensitivity 51 67 2139 2155 O
reactions 68 77 2156 2165 O
to 78 80 2166 2168 O
chimeric 81 89 2169 2177 B-allergy_name
or 90 92 2178 2180 O
humanized 93 102 2181 2190 B-allergy_name
antibodies 103 113 2191 2201 I-allergy_name
or 114 116 2202 2204 O
fusion 117 123 2205 2211 B-allergy_name
proteins 124 132 2212 2220 I-allergy_name

Inactivated 0 11 2221 2232 B-treatment
vaccines 12 20 2233 2241 I-treatment
( 21 22 2242 2243 O
such 22 26 2243 2247 O
as 27 29 2248 2250 O
hepatitis 30 39 2251 2260 B-treatment
A 40 41 2261 2262 I-treatment
or 42 44 2263 2265 O
polio 45 50 2266 2271 B-treatment
vaccines 51 59 2272 2280 I-treatment
) 59 60 2280 2281 O
are 61 64 2282 2285 O
permitted 65 74 2286 2295 O
during 75 81 2296 2302 O
the 82 85 2303 2306 O
study 86 91 2307 2312 O

Influenza 0 9 2313 2322 B-treatment
vaccination 10 21 2323 2334 I-treatment
should 22 28 2335 2341 O
be 29 31 2342 2344 O
given 32 37 2345 2350 O
during 38 44 2351 2357 O
influenza 45 54 2358 2367 B-chronic_disease
season 55 61 2368 2374 O
only 62 66 2375 2379 O
( 67 68 2380 2381 O
approximately 68 81 2381 2394 O
October 82 89 2395 2402 O
to 90 92 2403 2405 O
March 93 98 2406 2411 O
) 98 99 2411 2412 O

Intravesical 0 12 2413 2425 B-treatment
chemo- 13 19 2426 2432 I-treatment
or 20 22 2433 2435 O
biologic 23 31 2436 2444 B-treatment
therapy 32 39 2445 2452 I-treatment

Known 0 5 2453 2458 O
distant 6 13 2459 2466 O
metastatic 14 24 2467 2477 B-cancer
disease 25 32 2478 2485 I-cancer
( 33 34 2486 2487 O
e.g. 34 38 2487 2491 O
pulmonary 39 48 2492 2501 B-cancer
or 49 51 2502 2504 O
hepatic 52 59 2505 2512 B-cancer
metastases 60 70 2513 2523 I-cancer
) 70 71 2523 2524 O

Known 0 5 2525 2530 O
hypersensitivity 6 22 2531 2547 O
to 23 25 2548 2550 O
Chinese 26 33 2551 2558 B-allergy_name
hamster 34 41 2559 2566 I-allergy_name
ovary 42 47 2567 2572 I-allergy_name
( 48 49 2573 2574 I-allergy_name
CHO 49 52 2574 2577 I-allergy_name
) 52 53 2577 2578 I-allergy_name
cell 54 58 2579 2583 I-allergy_name
products 59 67 2584 2592 I-allergy_name
or 68 70 2593 2595 O
any 71 74 2596 2599 O
component 75 84 2600 2609 B-allergy_name
of 85 87 2610 2612 I-allergy_name
the 88 91 2613 2616 I-allergy_name
MPDL3280A 92 101 2617 2626 I-allergy_name
formulation 102 113 2627 2638 I-allergy_name

Major 0 5 2639 2644 B-treatment
surgical 6 14 2645 2653 I-treatment
procedure 15 24 2654 2663 O
other 25 30 2664 2669 O
than 31 35 2670 2674 O
for 36 39 2675 2678 O
diagnosis 40 49 2679 2688 O
within 50 56 2689 2695 O
28 57 59 2696 2698 B-lower_bound
days 60 64 2699 2703 I-lower_bound
prior 65 70 2704 2709 I-lower_bound
to 71 73 2710 2712 O
Cycle 74 79 2713 2718 O
1 80 81 2719 2720 O
, 81 82 2720 2721 O
Day 83 86 2722 2725 O
1 87 88 2726 2727 O

Malignancies 0 12 2728 2740 B-cancer
other 13 18 2741 2746 O
than 19 23 2747 2751 O
UC 24 26 2752 2754 B-chronic_disease
within 27 33 2755 2761 O
5 34 35 2762 2763 B-upper_bound
years 36 41 2764 2769 I-upper_bound
prior 42 47 2770 2775 I-upper_bound
to 48 50 2776 2778 O
Cycle 51 56 2779 2784 O
1 57 58 2785 2786 O
, 58 59 2786 2787 O
Day 60 63 2788 2791 O
1 64 65 2792 2793 O
, 65 66 2793 2794 O
with 67 71 2795 2799 O
the 72 75 2800 2803 O
exception 76 85 2804 2813 O
of 86 88 2814 2816 O
those 89 94 2817 2822 O
with 95 99 2823 2827 O
a 100 101 2828 2829 O
low 102 105 2830 2833 O
risk 106 110 2834 2838 O
of 111 113 2839 2841 O
metastasis 114 124 2842 2852 B-treatment

Patients 0 8 2853 2861 O
may 9 12 2862 2865 O
be 13 15 2866 2868 O
transfused 16 26 2869 2879 O
or 27 29 2880 2882 O
receive 30 37 2883 2890 O
erythropoietic 38 52 2891 2905 B-treatment
treatment 53 62 2906 2915 I-treatment
to 63 65 2916 2918 O
meet 66 70 2919 2923 O
this 71 75 2924 2928 O
criterion 76 85 2929 2938 O

Patients 0 8 2939 2947 O
must 9 13 2948 2952 O
not 14 17 2953 2956 O
receive 18 25 2957 2964 O
live 26 30 2965 2969 B-treatment
attenuated 31 41 2970 2980 I-treatment
influenza 42 51 2981 2990 I-treatment
vaccine 52 59 2991 2998 I-treatment
( 60 61 2999 3000 O
e.g. 61 65 3000 3004 O
, 65 66 3004 3005 O
FluMist 67 74 3006 3013 B-treatment
) 74 75 3013 3014 O
within 76 82 3015 3021 O
4 83 84 3022 3023 B-upper_bound
weeks 85 90 3024 3029 I-upper_bound
prior 91 96 3030 3035 I-upper_bound
to 97 99 3036 3038 O
Cycle 100 105 3039 3044 O
1 106 107 3045 3046 O
, 107 108 3046 3047 O
Day 109 112 3048 3051 O
1 113 114 3052 3053 O
and 115 118 3054 3057 O
for 119 122 3058 3061 O
at 123 125 3062 3064 O
least 126 131 3065 3070 O
12 132 134 3071 3073 B-lower_bound
weeks 135 140 3074 3079 I-lower_bound
after 141 146 3080 3085 I-lower_bound
the 147 150 3086 3089 O
last 151 155 3090 3094 O
dose 156 160 3095 3099 O

Patients 0 8 3100 3108 O
who 9 12 3109 3112 O
have 13 17 3113 3117 O
received 18 26 3118 3126 O
acute 27 32 3127 3132 O
, 32 33 3132 3133 O
low 34 37 3134 3137 O
- 37 38 3137 3138 O
dose 38 42 3138 3142 O
, 42 43 3142 3143 O
systemic 44 52 3144 3152 B-treatment
immunosuppressant 53 70 3153 3170 I-treatment
medications 71 82 3171 3182 I-treatment
( 83 84 3183 3184 O
e.g. 84 88 3184 3188 O
, 88 89 3188 3189 O
a 90 91 3190 3191 O
one 92 95 3192 3195 O
- 95 96 3195 3196 O
time 96 100 3196 3200 O
dose 101 105 3201 3205 O
of 106 108 3206 3208 O
dexamethasone 109 122 3209 3222 B-treatment
for 123 126 3223 3226 O
nausea 127 133 3227 3233 B-chronic_disease
) 133 134 3233 3234 O
may 135 138 3235 3238 O
be 139 141 3239 3241 O
enrolled 142 150 3242 3250 O
in 151 153 3251 3253 O
the 154 157 3254 3257 O
study 158 163 3258 3263 O
after 164 169 3264 3269 O
discussion 170 180 3270 3280 O
with 181 185 3281 3285 O
and 186 189 3286 3289 O
approval 190 198 3290 3298 O
by 199 201 3299 3301 O
the 202 205 3302 3305 O
Study 206 211 3306 3311 O
Chair 212 217 3312 3317 O

Patients 0 8 3318 3326 O
with 9 13 3327 3331 O
a 14 15 3332 3333 O
history 16 23 3334 3341 O
of 24 26 3342 3344 O
autoimmune 27 37 3345 3355 O
- 37 38 3355 3356 O
related 38 45 3356 3363 O
hypothyroidism 46 60 3364 3378 B-chronic_disease
on 61 63 3379 3381 O
a 64 65 3382 3383 O
stable 66 72 3384 3390 O
dose 73 77 3391 3395 O
of 78 80 3396 3398 O
thyroid 81 88 3399 3406 B-treatment
replacement 89 100 3407 3418 I-treatment
hormone 101 108 3419 3426 I-treatment
are 109 112 3427 3430 O
eligible 113 121 3431 3439 O
for 122 125 3440 3443 O
this 126 130 3444 3448 O
study 131 136 3449 3454 O

Patients 0 8 3455 3463 O
with 9 13 3464 3468 O
controlled 14 24 3469 3479 O
Type 25 29 3480 3484 B-chronic_disease
I 30 31 3485 3486 I-chronic_disease
diabetes 32 40 3487 3495 I-chronic_disease
mellitus 41 49 3496 3504 I-chronic_disease
on 50 52 3505 3507 O
a 53 54 3508 3509 O
stable 55 61 3510 3516 O
dose 62 66 3517 3521 O
of 67 69 3522 3524 O
insulin 70 77 3525 3532 B-treatment
regimen 78 85 3533 3540 O
are 86 89 3541 3544 O
eligible 90 98 3545 3553 O
for 99 102 3554 3557 O
this 103 107 3558 3562 O
study 108 113 3563 3568 O

Patients 0 8 3569 3577 O
with 9 13 3578 3582 O
known 14 19 3583 3588 O
coronary 20 28 3589 3597 B-chronic_disease
artery 29 35 3598 3604 I-chronic_disease
disease 36 43 3605 3612 I-chronic_disease
, 43 44 3612 3613 O
congestive 45 55 3614 3624 B-chronic_disease
heart 56 61 3625 3630 I-chronic_disease
failure 62 69 3631 3638 I-chronic_disease
not 70 73 3639 3642 O
meeting 74 81 3643 3650 O
the 82 85 3651 3654 O
above 86 91 3655 3660 O
criteria 92 100 3661 3669 O
, 100 101 3669 3670 O
or 102 104 3671 3673 O
left 105 109 3674 3678 B-chronic_disease
ventricular 110 121 3679 3690 I-chronic_disease
ejection 122 130 3691 3699 I-chronic_disease
fraction 131 139 3700 3708 I-chronic_disease

Patients 0 8 3709 3717 O
with 9 13 3718 3722 O
past 14 18 3723 3727 O
HBV 19 22 3728 3731 B-chronic_disease
infection 23 32 3732 3741 I-chronic_disease
or 33 35 3742 3744 O
resolved 36 44 3745 3753 O
HBV 45 48 3754 3757 O
infection 49 58 3758 3767 O
( 59 60 3768 3769 O
defined 60 67 3769 3776 O
as 68 70 3777 3779 O
the 71 74 3780 3783 O
presence 75 83 3784 3792 O
of 84 86 3793 3795 O
hepatitis 87 96 3796 3805 B-clinical_variable
B 97 98 3806 3807 I-clinical_variable
core 99 103 3808 3812 I-clinical_variable
antibody 104 112 3813 3821 I-clinical_variable
[ 113 114 3822 3823 I-clinical_variable
HBc 114 117 3823 3826 I-clinical_variable
Ab 118 120 3827 3829 I-clinical_variable
] 120 121 3829 3830 I-clinical_variable
and 122 125 3831 3834 O
absence 126 133 3835 3842 O
of 134 136 3843 3845 O
HBsAg 137 142 3846 3851 B-clinical_variable
) 142 143 3851 3852 O
are 144 147 3853 3856 O
eligible 148 156 3857 3865 O

Platelet 0 8 3866 3874 B-clinical_variable
count 9 14 3875 3880 I-clinical_variable
> 15 16 3881 3882 O
100,000 17 24 3883 3890 B-lower_bound
cells 25 30 3891 3896 I-lower_bound
/ 30 31 3896 3897 I-lower_bound
mm3 31 34 3897 3900 I-lower_bound

Pregnant 0 8 3901 3909 B-pregnancy

Presence 0 8 3910 3918 O
of 9 11 3919 3921 O
PD 12 14 3922 3924 O
- 14 15 3924 3925 O
L1 15 17 3925 3927 O
antigen 18 25 3928 3935 O
on 26 28 3936 3938 O
tumors 29 35 3939 3945 B-cancer
is 36 38 3946 3948 O
NOT 39 42 3949 3952 O
required 43 51 3953 3961 O
for 52 55 3962 3965 O
study 56 61 3966 3971 O
entry 62 67 3972 3977 O

Prior 0 5 3978 3983 B-treatment
allogeneic 6 16 3984 3994 I-treatment
stem 17 21 3995 3999 I-treatment
cell 22 26 4000 4004 I-treatment
or 27 29 4005 4007 O
solid 30 35 4008 4013 B-treatment
organ 36 41 4014 4019 I-treatment
transplant 42 52 4020 4030 I-treatment

Prior 0 5 4031 4036 B-treatment
systemic 6 14 4037 4045 I-treatment
chemotherapy 15 27 4046 4058 I-treatment
or 28 30 4059 4061 O
radiation 31 40 4062 4071 B-treatment
therapy 41 48 4072 4079 I-treatment
for 49 52 4080 4083 O
transitional 53 65 4084 4096 B-cancer
cell 66 70 4097 4101 I-cancer
carcinoma 71 80 4102 4111 I-cancer
of 81 83 4112 4114 I-cancer
the 84 87 4115 4118 I-cancer
bladder 88 95 4119 4126 I-cancer

Prior 0 5 4127 4132 B-treatment
treatment 6 15 4133 4142 I-treatment
with 16 20 4143 4147 I-treatment
CD137 21 26 4148 4153 I-treatment
agonists 27 35 4154 4162 I-treatment
or 36 38 4163 4165 I-treatment
immune 39 45 4166 4172 I-treatment
checkpoint 46 56 4173 4183 I-treatment
blockade 57 65 4184 4192 I-treatment
therapies 66 75 4193 4202 I-treatment
, 75 76 4202 4203 O
including 77 86 4204 4213 O
anti 87 91 4214 4218 B-treatment
CTLA-4 92 98 4219 4225 I-treatment
, 98 99 4225 4226 O
anti 100 104 4227 4231 B-treatment
- 104 105 4231 4232 I-treatment
PD1 105 108 4232 4235 I-treatment
and 109 112 4236 4239 I-treatment
anti 113 117 4240 4244 I-treatment
- 117 118 4244 4245 I-treatment
PD 118 120 4245 4247 I-treatment
- 120 121 4247 4248 I-treatment
L1 121 123 4248 4250 I-treatment
therapeutic 124 135 4251 4262 I-treatment
antibodies 136 146 4263 4273 I-treatment

Serum 0 5 4274 4279 B-clinical_variable
bilirubin 6 15 4280 4289 I-clinical_variable
< 16 17 4290 4291 O
1.5 18 21 4292 4295 B-upper_bound
x 22 23 4296 4297 I-upper_bound
ULN 24 27 4298 4301 I-upper_bound
( 28 29 4302 4303 O
except 29 35 4303 4309 O
for 36 39 4310 4313 O
patients 40 48 4314 4322 O
with 49 53 4323 4327 O
documented 54 64 4328 4338 O
Gilbert 65 72 4339 4346 B-chronic_disease
's 72 74 4346 4348 I-chronic_disease
disease 75 82 4349 4356 I-chronic_disease
) 82 83 4356 4357 O

Serum 0 5 4358 4363 B-clinical_variable
creatinine 6 16 4364 4374 I-clinical_variable
< 17 18 4375 4376 O
2 19 20 4377 4378 B-upper_bound
mg 21 23 4379 4381 I-upper_bound
/ 23 24 4381 4382 I-upper_bound
dL 24 26 4382 4384 I-upper_bound
OR 27 29 4385 4387 O
calculated 30 40 4388 4398 B-clinical_variable
CrCl 41 45 4399 4403 I-clinical_variable
> 46 47 4404 4405 O
30ml 48 52 4406 4410 B-lower_bound
/ 52 53 4410 4411 I-lower_bound
min 53 56 4411 4414 I-lower_bound

Severe 0 6 4415 4421 O
infections 7 17 4422 4432 B-chronic_disease
within 18 24 4433 4439 O
4 25 26 4440 4441 B-upper_bound
weeks 27 32 4442 4447 I-upper_bound
prior 33 38 4448 4453 I-upper_bound
to 39 41 4454 4456 O
Cycle 42 47 4457 4462 O
1 48 49 4463 4464 O
, 49 50 4464 4465 O
Day 51 54 4466 4469 O
1 55 56 4470 4471 O
, 56 57 4471 4472 O
including 58 67 4473 4482 O
but 68 71 4483 4486 O
not 72 75 4487 4490 O
limited 76 83 4491 4498 O
to 84 86 4499 4501 O
hospitalization 87 102 4502 4517 O
for 103 106 4518 4521 O
complications 107 120 4522 4535 O
of 121 123 4536 4538 O
infection 124 133 4539 4548 O
, 133 134 4548 4549 O
bacteremia 135 145 4550 4560 B-chronic_disease
, 145 146 4560 4561 O
or 147 149 4562 4564 O
severe 150 156 4565 4571 O
pneumonia 157 166 4572 4581 B-chronic_disease

Significant 0 11 4582 4593 O
cardiovascular 12 26 4594 4608 B-chronic_disease
disease 27 34 4609 4616 I-chronic_disease
, 34 35 4616 4617 O
such 36 40 4618 4622 O
as 41 43 4623 4625 O
New 44 47 4626 4629 B-clinical_variable
York 48 52 4630 4634 I-clinical_variable
Heart 53 58 4635 4640 I-clinical_variable
Association 59 70 4641 4652 I-clinical_variable
cardiac 71 78 4653 4660 I-clinical_variable
disease 79 86 4661 4668 I-clinical_variable
( 87 88 4669 4670 O
Class 88 93 4670 4675 B-lower_bound
II 94 96 4676 4678 I-lower_bound
or 97 99 4679 4681 O
greater 100 107 4682 4689 O
) 107 108 4689 4690 O
, 108 109 4690 4691 O
myocardial 110 120 4692 4702 B-chronic_disease
infarction 121 131 4703 4713 I-chronic_disease
within 132 138 4714 4720 O
the 139 142 4721 4724 O
previous 143 151 4725 4733 B-upper_bound
3 152 153 4734 4735 I-upper_bound
months 154 160 4736 4742 I-upper_bound
, 160 161 4742 4743 O
unstable 162 170 4744 4752 O
arrhythmias 171 182 4753 4764 B-chronic_disease
, 182 183 4764 4765 O
or 184 186 4766 4768 O
unstable 187 195 4769 4777 B-chronic_disease
angina 196 202 4778 4784 I-chronic_disease

Subjects 0 8 4785 4793 O
who 9 12 4794 4797 O
have 13 17 4798 4802 O
received 18 26 4803 4811 O
prior 27 32 4812 4817 B-treatment
intravesical 33 45 4818 4830 I-treatment
chemotherapy 46 58 4831 4843 I-treatment
are 59 62 4844 4847 O
allowed 63 70 4848 4855 O

Subjects 0 8 4856 4864 O
with 9 13 4865 4869 O
MIBC 14 18 4870 4874 O
not 19 22 4875 4878 O
meeting 23 30 4879 4886 O
the 31 34 4887 4890 O
above 35 40 4891 4896 O
criteria 41 49 4897 4905 O
are 50 53 4906 4909 O
still 54 59 4910 4915 O
eligible 60 68 4916 4924 O
provided 69 77 4925 4933 O
the 78 81 4934 4937 O
patient 82 89 4938 4945 O
declines 90 98 4946 4954 O
neoadjuvant 99 110 4955 4966 B-treatment
cisplatin 111 120 4967 4976 I-treatment
- 120 121 4976 4977 I-treatment
based 121 126 4977 4982 I-treatment
chemotherapy 127 139 4983 4995 I-treatment
, 139 140 4995 4996 O
after 141 146 4997 5002 O
specific 147 155 5003 5011 O
informed 156 164 5012 5020 O
consent 165 172 5021 5028 O
describing 173 183 5029 5039 O
the 184 187 5040 5043 O
known 188 193 5044 5049 O
benefits 194 202 5050 5058 O
of 203 205 5059 5061 O
cisplatin 206 215 5062 5071 O
- 215 216 5071 5072 O
based 216 221 5072 5077 O
chemotherapy 222 234 5078 5090 O

Subjects 0 8 5091 5099 O
with 9 13 5100 5104 O
NMIBC 14 19 5105 5110 B-cancer
must 20 24 5111 5115 O
be 25 27 5116 5118 O
suitable 28 36 5119 5127 O
for 37 40 5128 5131 O
and 41 44 5132 5135 O
willing 45 52 5136 5143 O
to 53 55 5144 5146 O
undergo 56 63 5147 5154 O
a 64 65 5155 5156 O
radical 66 73 5157 5164 O
cystectomy 74 84 5165 5175 B-treatment
at 85 87 5176 5178 O
the 88 91 5179 5182 O
completion 92 102 5183 5193 O
of 103 105 5194 5196 O
study 106 111 5197 5202 O
therapy 112 119 5203 5210 B-treatment

Subjects 0 8 5211 5219 O
with 9 13 5220 5224 O
malignant 14 23 5225 5234 B-treatment
lymphadenectomy 24 39 5235 5250 I-treatment
in 40 42 5251 5253 O
the 43 46 5254 5257 O
abdomen 47 54 5258 5265 O
or 55 57 5266 5268 O
pelvis 58 64 5269 5275 O
considered 65 75 5276 5286 O
appropriate 76 87 5287 5298 O
for 88 91 5299 5302 O
radical 92 99 5303 5310 B-treatment
cystectomy 100 110 5311 5321 I-treatment
and 111 114 5322 5325 O
lymphadnectomy 115 129 5326 5340 B-treatment
with 130 134 5341 5345 O
the 135 138 5346 5349 O
goal 139 143 5350 5354 O
of 144 146 5355 5357 O
complete 147 155 5358 5366 O
resection 156 165 5367 5376 O
of 166 168 5377 5379 O
all 169 172 5380 5383 O
malignant 173 182 5384 5393 O
disease 183 190 5394 5401 O
are 191 194 5402 5405 O
allowed 195 202 5406 5413 O

Subjects 0 8 5414 5422 O
with 9 13 5423 5427 O
primary 14 21 5428 5435 O
TCC 22 25 5436 5439 B-cancer
of 26 28 5440 5442 O
the 29 32 5443 5446 O
ureter 33 39 5447 5453 O
, 39 40 5453 5454 O
urethra 41 48 5455 5462 O
, 48 49 5462 5463 O
or 50 52 5464 5466 O
renal 53 58 5467 5472 O
pelvis 59 65 5473 5479 O
without 66 73 5480 5487 O
TCC 74 77 5488 5491 O
of 78 80 5492 5494 O
the 81 84 5495 5498 O
bladder 85 92 5499 5506 O
are 93 96 5507 5510 O
not 97 100 5511 5514 O
allowed 101 108 5515 5522 O

The 0 3 5523 5526 O
effects 4 11 5527 5534 O
of 12 14 5535 5537 O
MPDL3280A 15 24 5538 5547 B-treatment
on 25 27 5548 5550 O
the 28 31 5551 5554 O
developing 32 42 5555 5565 O
human 43 48 5566 5571 O
fetus 49 54 5572 5577 O
are 55 58 5578 5581 O
unknown 59 66 5582 5589 O

The 0 3 5590 5593 O
use 4 7 5594 5597 O
of 8 10 5598 5600 O
inhaled 11 18 5601 5608 B-treatment
corticosteroids 19 34 5609 5624 I-treatment
and 35 38 5625 5628 O
mineralocorticoids 39 57 5629 5647 B-treatment
( 58 59 5648 5649 O
e.g. 59 63 5649 5653 O
, 63 64 5653 5654 O
fludrocortisone 65 80 5655 5670 B-treatment
for 81 84 5671 5674 O
adrenal 85 92 5675 5682 B-chronic_disease
insufficiency 93 106 5683 5696 I-chronic_disease
) 106 107 5696 5697 O
is 108 110 5698 5700 O
allowed 111 118 5701 5708 O

Treatment 0 9 5709 5718 B-treatment
with 10 14 5719 5723 I-treatment
systemic 15 23 5724 5732 I-treatment
corticosteroids 24 39 5733 5748 I-treatment
or 40 42 5749 5751 O
other 43 48 5752 5757 O
systemic 49 57 5758 5766 B-treatment
immunosuppressive 58 75 5767 5784 I-treatment
medications 76 87 5785 5796 I-treatment
( 88 89 5797 5798 O
including 89 98 5798 5807 O
but 99 102 5808 5811 O
not 103 106 5812 5815 O
limited 107 114 5816 5823 O
to 115 117 5824 5826 O
prednisone 118 128 5827 5837 B-treatment
, 128 129 5837 5838 O
dexamethasone 130 143 5839 5852 B-treatment
, 143 144 5852 5853 O
cyclophosphamide 145 161 5854 5870 B-treatment
, 161 162 5870 5871 O
azathioprine 163 175 5872 5884 B-treatment
, 175 176 5884 5885 O
methotrexate 177 189 5886 5898 B-treatment
, 189 190 5898 5899 O
thalidomide 191 202 5900 5911 B-treatment
, 202 203 5911 5912 O
and 204 207 5913 5916 O
anti 208 212 5917 5921 B-treatment
- 212 213 5921 5922 I-treatment
tumor 213 218 5922 5927 I-treatment
necrosis 219 227 5928 5936 I-treatment
factor 228 234 5937 5943 I-treatment
[ 235 236 5944 5945 I-treatment
anti 236 240 5945 5949 I-treatment
- 240 241 5949 5950 I-treatment
TNF 241 244 5950 5953 I-treatment
] 244 245 5953 5954 I-treatment
agents 246 252 5955 5961 I-treatment

Uncontrolled 0 12 5962 5974 O
cystitis 13 21 5975 5983 B-chronic_disease
, 21 22 5983 5984 O
significant 23 34 5985 5996 O
bladder 35 42 5997 6004 B-chronic_disease
pain 43 47 6005 6009 I-chronic_disease
or 48 50 6010 6012 I-chronic_disease
spasms 51 57 6013 6019 I-chronic_disease
, 57 58 6019 6020 O
or 59 61 6021 6023 O
gross 62 67 6024 6029 B-chronic_disease
hematuria 68 77 6030 6039 I-chronic_disease
that 78 82 6040 6044 O
in 83 85 6045 6047 O
the 86 89 6048 6051 O
opinion 90 97 6052 6059 O
of 98 100 6060 6062 O
the 101 104 6063 6066 O
treating 105 113 6067 6075 O
investigator 114 126 6076 6088 O
, 126 127 6088 6089 O
should 128 134 6090 6096 O
preclude 135 143 6097 6105 O
study 144 149 6106 6111 O
entry 150 155 6112 6117 O

WBC 0 3 6118 6121 B-clinical_variable
> 4 5 6122 6123 O
2500 6 10 6124 6128 B-lower_bound
cells 11 16 6129 6134 I-lower_bound
/ 16 17 6134 6135 I-lower_bound
mm3 17 20 6135 6138 I-lower_bound

anticipation 0 12 6139 6151 O
of 13 15 6152 6154 O
need 16 20 6155 6159 O
for 21 24 6160 6163 O
a 25 26 6164 6165 O
major 27 32 6166 6171 B-treatment
surgical 33 41 6172 6180 I-treatment
procedure 42 51 6181 6190 I-treatment
other 52 57 6191 6196 O
than 58 62 6197 6201 O
cystectomy 63 73 6202 6212 B-treatment
during 74 80 6213 6219 O
the 81 84 6220 6223 O
course 85 91 6224 6230 O
of 92 94 6231 6233 O
the 95 98 6234 6237 O
study 99 104 6238 6243 O

cancer 0 6 6244 6250 B-cancer
recurrence 7 17 6251 6261 O
within 18 24 6262 6268 O
1 25 26 6269 6270 B-upper_bound
year 27 31 6271 6275 I-upper_bound
of 32 34 6276 6278 O
initiation 35 45 6279 6289 O
of 46 48 6290 6292 O
therapy 49 56 6293 6300 B-treatment
for 57 60 6301 6304 O
patients 61 69 6305 6313 O
who 70 73 6314 6317 O
have 74 78 6318 6322 O
received 79 87 6323 6331 O
induction 88 97 6332 6341 O
plus 98 102 6342 6346 O
maintenance 103 114 6347 6358 B-treatment
BCG 115 118 6359 6362 I-treatment
therapy 119 126 6363 6370 I-treatment

death 0 5 6371 6376 O
treated 6 13 6377 6384 O
with 14 18 6385 6389 O
expected 19 27 6390 6398 O
curative 28 36 6399 6407 O
outcome 37 44 6408 6415 O
( 45 46 6416 6417 O
such 46 50 6417 6421 O
as 51 53 6422 6424 O
, 53 54 6424 6425 O
but 55 58 6426 6429 O
not 59 62 6430 6433 O
limited 63 70 6434 6441 O
to 71 73 6442 6444 O
, 73 74 6444 6445 O
adequately 75 85 6446 6456 O
treated 86 93 6457 6464 O
carcinoma 94 103 6465 6474 B-cancer
in 104 106 6475 6477 I-cancer
situ 107 111 6478 6482 I-cancer
of 112 114 6483 6485 I-cancer
the 115 118 6486 6489 I-cancer
cervix 119 125 6490 6496 I-cancer
, 125 126 6496 6497 O
basal 127 132 6498 6503 B-cancer
or 133 135 6504 6506 O
squamous 136 144 6507 6515 B-cancer
cell 145 149 6516 6520 I-cancer
skin 150 154 6521 6525 I-cancer
cancer 155 161 6526 6532 I-cancer
, 161 162 6532 6533 O
localized 163 172 6534 6543 O
prostate 173 181 6544 6552 B-cancer
cancer 182 188 6553 6559 I-cancer
treated 189 196 6560 6567 O
with 197 201 6568 6572 O
curative 202 210 6573 6581 O
intent 211 217 6582 6588 O
and 218 221 6589 6592 O
absence 222 229 6593 6600 O
of 230 232 6601 6603 O
PSA 233 236 6604 6607 O
relapse 237 244 6608 6615 O
, 244 245 6615 6616 O
or 246 248 6617 6619 O
ductal 249 255 6620 6626 B-cancer
carcinoma 256 265 6627 6636 I-cancer
in 266 268 6637 6639 I-cancer
situ 269 273 6640 6644 I-cancer
of 274 276 6645 6647 O
the 277 280 6648 6651 O
breast 281 287 6652 6658 O
treated 288 295 6659 6666 O
surgically 296 306 6667 6677 O
with 307 311 6678 6682 O
curative 312 320 6683 6691 O
intent 321 327 6692 6698 O
) 327 328 6698 6699 O

incidental 0 10 6700 6710 O
prostate 11 19 6711 6719 B-cancer
cancer 20 26 6720 6726 I-cancer
( 27 28 6727 6728 O
T1a 28 31 6728 6731 O
, 31 32 6731 6732 O
Gleason 33 40 6733 6740 B-clinical_variable
score 41 46 6741 6746 I-clinical_variable
â‰¤ 47 48 6747 6748 O
6 49 50 6749 6750 B-upper_bound
and 51 54 6751 6754 O
PSA 55 58 6755 6758 B-clinical_variable
< 59 60 6759 6760 O
0.5 61 64 6761 6764 B-upper_bound
ng 65 67 6765 6767 I-upper_bound
/ 67 68 6767 6768 I-upper_bound
mL 68 70 6768 6770 I-upper_bound
) 70 71 6770 6771 O

maintenance 0 11 6772 6783 O
OR 12 14 6784 6786 O
two 15 18 6787 6790 O
induction 19 28 6791 6800 B-treatment
courses 29 36 6801 6808 I-treatment
of 37 39 6809 6811 I-treatment
BCG 40 43 6812 6815 I-treatment

nursing 0 7 6816 6823 O
women 8 13 6824 6829 B-gender
are 14 17 6830 6833 O
excluded 18 26 6834 6842 O

within 0 6 6843 6849 O
2 7 8 6850 6851 B-upper_bound
weeks 9 14 6852 6857 I-upper_bound
prior 15 20 6858 6863 I-upper_bound
to 21 23 6864 6866 O
Cycle 24 29 6867 6872 O
1 30 31 6873 6874 O
, 31 32 6874 6875 O
Day 33 36 6876 6879 O
1 37 38 6880 6881 O
, 38 39 6881 6882 O
or 40 42 6883 6885 O
anticipated 43 54 6886 6897 O
requirement 55 66 6898 6909 O
for 67 70 6910 6913 O
systemic 71 79 6914 6922 B-treatment
immunosuppressive 80 97 6923 6940 I-treatment
medications 98 109 6941 6952 I-treatment
during 110 116 6953 6959 O
the 117 120 6960 6963 O
trial 121 126 6964 6969 O

within 0 6 6970 6976 O
6 7 8 6977 6978 B-upper_bound
weeks 9 14 6979 6984 I-upper_bound
of 15 17 6985 6987 O
first 18 23 6988 6993 B-treatment
treatment 24 33 6994 7003 I-treatment

